Sp269
AN OVERVIEW OF GI INVOLVEMENT IN PD; IS CONSTIPATION A POTENTIAL BIOMARKER OF PD?
Date
May 18, 2024
Presenter
Mayo Clinic
Tracks
Related Products
Challenging Clinical Controversies in Neurogastroenterology
LIVE STREAM SESSION DDW attendees will hear expert opinions on controversial topics in the challenging clinical care of Neurogastroenterology. Attendees can decide which position works best for their clinical care…
DEVELOPMENT AND VALIDATION OF THE MINNESOTA FECAL INCONTINENCE QUALITY OF LIFE (FIQL) SCALE
BACKGROUND AND AIMS. Fecal incontinence (FI) symptoms can markedly impair quality of life (QoL)…
CONSTIPATION IN A LARGE ONLINE COHORT OF PERSONS WITH PARKINSON DISEASE
BACKGROUND. Our understanding of constipation, a common symptom in persons with Parkinson’s disease (PwPD), is based on small cohorts. The relationship between constipation and other non-motor and motor symptoms of PD at the outset and over time is unclear…
DIFFERENCES IN MECHANISMS OF NORMAL AND DISORDERED DEFECATION BETWEEN MEN AND WOMEN
BACKGROUND AND AIMS. Among healthy persons (PMID 30957382) and constipated patients (PMID 27891696), anorectal pressures measured in an empty rectum in the lateral position differ between men and women. These studies did not assess rectal evacuation…
